We are live on ! Find out more
SR

Syntax Research Portfolio holdings

AUM $157M
1-Year Est. Return 16.51%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+16.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$4.04M
Cap. Flow
-$11.9M
Cap. Flow %
-8.48%
Top 10 Hldgs %
46.39%
Holding
182
New
7
Increased
31
Reduced
30
Closed
12

Top Buys

1
TMO icon
Thermo Fisher Scientific
TMO
+$2.35M
2
ZTS icon
Zoetis
ZTS
+$2.21M
3
WTW icon
Willis Towers Watson
WTW
+$2.17M
4
PANW icon
Palo Alto Networks
PANW
+$2.16M
5
ACN icon
Accenture
ACN
+$2.03M

Top Sells

1
NTR icon
Nutrien
NTR
+$3.4M
2
AMT icon
American Tower
AMT
+$3.32M
3
NEM icon
Newmont
NEM
+$3.21M
4
COLD icon
Americold
COLD
+$2.6M
5
MRK icon
Merck
MRK
+$2.39M

Sector Composition

1 Technology 19.94%
2 Healthcare 5.03%
3 Industrials 4.92%
4 Financials 4.5%
5 Materials 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DE icon
126
Deere & Co
DE
$161B
$13.7K 0.01%
27
– –
SHW icon
127
Sherwin-Williams
SHW
$81.7B
$13.4K 0.01%
39
– –
PEP icon
128
PepsiCo
PEP
$187B
$13.2K 0.01%
100
– –
MELI icon
129
Mercado Libre
MELI
$92B
$13.1K 0.01%
5
– –
MNST icon
130
Monster Beverage
MNST
$95.4B
$12.5K 0.01%
200
– –
CRSP icon
131
CRISPR Therapeutics
CRSP
$4.71B
$12.2K 0.01%
250
– –
ADP icon
132
Automatic Data Processing
ADP
$102B
$12K 0.01%
39
– –
BKNG icon
133
Booking.com
BKNG
$141B
$11.6K 0.01%
50
– –
SJM icon
134
J.M. Smucker
SJM
$12B
$11K 0.01%
112
– –
CSX icon
135
CSX Corp
CSX
$94.3B
$10.6K 0.01%
324
– –
GH icon
136
Guardant Health
GH
$20.7B
$10.4K 0.01%
200
– –
CWB icon
137
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.78B
$10.1K 0.01%
122
-109
-47% -$8.56K
GDX icon
138
VanEck Gold Miners ETF
GDX
$21.8B
$9.47K 0.01%
182
– –
AMAT icon
139
Applied Materials
AMAT
$421B
$8.97K 0.01%
49
– –
CARR icon
140
Carrier Global
CARR
$57.1B
$8.64K 0.01%
118
– –
GS icon
141
Goldman Sachs
GS
$314B
$8.49K 0.01%
12
– –
WYNN icon
142
Wynn Resorts
WYNN
$10B
$8.34K 0.01%
89
– –
UAL icon
143
United Airlines
UAL
$37.5B
$7.96K 0.01%
100
– –
PFF icon
144
iShares Preferred and Income Securities ETF
PFF
$13.3B
$7.82K 0.01%
255
-281
-52% -$8.46K
CCJ icon
145
Cameco
CCJ
$37.3B
$7.42K 0.01%
100
– –
CCL icon
146
Carnival Corporation Ltd
CCL
$36.2B
$7.31K 0.01%
260
– –
MCD icon
147
McDonald's
MCD
$190B
$7.3K 0.01%
25
– –
DD icon
148
DuPont de Nemours
DD
$18.3B
$6.86K ﹤0.01%
80
– –
BX icon
149
Blackstone
BX
$155B
$6.62K ﹤0.01%
44
– –
MGM icon
150
MGM Resorts International
MGM
$11.8B
$6.54K ﹤0.01%
190
– –
4 5
6
7 8

Similar funds

BRWM
Blue Rock Wealth Management Winston-Salem, North Carolina $157M AUM 18.03% 1-Year Est. Return
SF
Seros Financial Tempe, Arizona $157M AUM 16.95% 1-Year Est. Return
AC
AlpenGlobal Capital Tahoe City, California $157M AUM
HEM
Henson-Edgewater Management Avon, Ohio $157M AUM
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
TPBG
Turning Point Benefit Group Frederick, Maryland $157M AUM 20.14% 1-Year Est. Return
CFG
Certior Financial Group King Of Prussia, Pennsylvania $157M AUM 12.22% 1-Year Est. Return

Syntax Research's Q2 2025 Portfolio in Review

As of Q2 2025, Syntax Research held 182 positions worth $141M, down 2.8% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Syntax Research withdrew a net $11.9M in Q2 2025, closing 12 positions and reducing 30 holdings. Its most notable exit was Americold, an estimated $2.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Syntax Research opened a new position in Zoetis worth $2.17M.

  • Syntax Research's largest Q2 2025 buy was Zoetis: 13,918 shares worth $2.17M.
  • Syntax Research added most to Thermo Fisher Scientific in Q2 2025, an estimated $2.35M increase.
  • Syntax Research's biggest Q2 2025 reduction was Nutrien, cutting an estimated $3.4M.
  • Syntax Research fully exited Americold in Q2 2025, selling an estimated $2.6M.
  • Syntax Research's ten largest holdings make up 46% of its $141M portfolio in Q2 2025.
  • Syntax Research opened 7 new positions and closed 12 in Q2 2025.
  • Syntax Research's portfolio value fell 2.8% quarter-over-quarter to $141M.

Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.